Generate a tailored SOP for Dr. Max Cryle. Improve your application with a focused, well-structured draft.
Max Cryle is a group leader at the EMBL Australia Victorian Node, which is based at the Department of Biochemistry and Molecular Biology at Monash University. He is also an associate investigator at the Australian Research Council Centre of Excellence in Advanced Molecular Imaging. He obtained his PhD in chemistry from the University of Queensland in 2006 and subsequently worked at the Max Planck Institute for Medical Research in Heidelberg as a Cross Disciplinary Fellow supported by the Human Frontiers Science Program. Dr. Cryle was awarded funding from the German Research Foundation to establish his own group to investigate glycopeptide antibiotic biosynthesis as part of the Emmy Noether program. His group operates at the intersection of chemistry and biology, employing a multidisciplinary approach that includes synthetic chemistry, biochemistry, and structural biology to study enzyme catalysis. In 2016, he joined EMBL Australia to further his research on the biosynthesis of essential natural antibiotics and the development of new antimicrobial agents, work that has been supported by an NHMRC Career Development Fellowship since 2018. His research interests align with the UN Sustainable Development Goals, particularly in the context of antibiotic development and biological chemistry.
EMBL Australia • Melbourne, VIC, Australia
Leading a research group focused on antibiotic biosynthesis.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.